Gastric Cancer Clinical Trials in Guangzhou, Guangdong
18 recruitingGuangzhou, Guangdong, China
Showing 1–18 of 18 trials
Recruiting
Phase 1
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Breast CancerGastric CancerOvarian Cancer+1 more
BeiGene258 enrolled24 locationsNCT06257264
Recruiting
Phase 1
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines140 enrolled20 locationsNCT06427941
Recruiting
Phase 1
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaMetastatic Cancer+5 more
I-Mab Biopharma US Limited330 enrolled21 locationsNCT04900818
Recruiting
Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric Cancer
Gastric CancerMolecular Imaging
Nanfang Hospital, Southern Medical University47 enrolled1 locationNCT07294638
Recruiting
Phase 1
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
Esophageal CancerPancreatic CancerGastric Cancer
Sichuan Baili Pharmaceutical Co., Ltd.20 enrolled1 locationNCT06500052
Recruiting
Phase 1
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Liver CancerGastric CancerSolid Tumor
Qurgen Inc.96 enrolled11 locationsNCT06873659
Recruiting
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Gastric CancerGastric UlcerGastritis+2 more
Nanfang Hospital, Southern Medical University10,000 enrolled1 locationNCT07032961
Recruiting
Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer
Gastric Cancers
Nanfang Hospital, Southern Medical University268 enrolled1 locationNCT07003334
Recruiting
Not Applicable
OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
Gastric Cancer
Nanfang Hospital, Southern Medical University344 enrolled12 locationsNCT05450835
Recruiting
Phase 2
Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore
Gastric Cancer
Nanfang Hospital, Southern Medical University92 enrolled1 locationNCT06157996
Recruiting
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269
Recruiting
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
Gastric CancerChemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University500 enrolled1 locationNCT06451393
Recruiting
Phase 2
Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
Gastric CancerStomach NeoplasmsLinitis Plastica of Stomach
Sun Yat-sen University53 enrolled1 locationNCT06451211
Recruiting
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Liver CancerGastric CancerCancer Diagnosis+1 more
Air Force Military Medical University, China3,200 enrolled8 locationsNCT06036563
Recruiting
Not Applicable
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
Gastric Cancer
Nanfang Hospital, Southern Medical University300 enrolled1 locationNCT05494086
Recruiting
Phase 2
Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric Cancer
Unresectable/Metastatic Gastric Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University40 enrolled1 locationNCT06365008
Recruiting
Phase 3
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Sun Yat-sen University540 enrolled10 locationsNCT05918094
Recruiting
Phase 2
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Gastric CancerGastroesophageal Junction Adenocarcinoma
RemeGen Co., Ltd.90 enrolled11 locationsNCT06155383